Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study.
Clark ED, Perin J, Herrmann N, Brawman-Mintzer O, Lanctôt KL, Lerner AJ, Mintzer J, Padala PR, Rosenberg PB, Sami S, Shade DM, van Dyck CH, Porsteinsson AP; ADMET‐2 Study Group.
Clark ED, et al. Among authors: sami s.
Alzheimers Dement (N Y). 2023 Aug 2;9(3):e12403. doi: 10.1002/trc2.12403. eCollection 2023 Jul-Sep.
Alzheimers Dement (N Y). 2023.
PMID: 37538343
Free PMC article.